Eye Lymphoma

Eye lymphoma, also known as ocular lymphoma, is a rare form of cancer that affects the lymphatic system in the eye. This type of lymphoma typically originates in the lymphocytes, a type of white blood cell, and can manifest in different parts of the eye, including the conjunctiva, iris, or retina. Research in eye lymphoma primarily focuses on understanding its pathogenesis, improving diagnostic techniques, and developing targeted therapies. Advances in imaging technologies such as optical coherence tomography (OCT) and molecular diagnostics have enhanced early detection and treatment monitoring. Additionally, novel treatment approaches including immunotherapy and targeted therapies tailored to specific genetic mutations are being explored to improve outcomes for patients with this challenging disease. Continued research efforts are crucial for advancing our understanding and management of eye lymphoma.